Regulation of Astroglial-Derived Dopaminergic Neurotrophic Factors by Interleukin-1β in the Striatum of Young and Middle-Aged Mice

Experimental Neurology

Volumn 148, Issue 1, 1997, Pages 348-359

  Ho, Angela ^a   Blum, Mariann ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOPAMINE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GDNF PROTEIN, MOUSE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1; MESSENGER RNA; NERVE GROWTH FACTOR; NERVE PROTEIN;

AGE; AGING; ANIMAL; ARTICLE; ASTROCYTE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; CORPUS STRIATUM; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOUSE; NERVE CELL PLASTICITY; PARKINSON DISEASE;

AGE FACTORS; AGING; ANIMALS; ASTROCYTES; CELLS, CULTURED; CORPUS STRIATUM; DNA, COMPLEMENTARY; DOPAMINE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN-1; MALE; MICE; MICE, INBRED C57BL; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; PARKINSON DISEASE; RNA, MESSENGER;

EID: 0031264356     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6659     Document Type: Article

References (83)

1. Agid, Y., F. Javoy-Agid,and M. Ruberg. 1987. Biochemistry of neurotransmitters in Parkinson's disease. In Movement Disorders (C. D. Marsden, and S. Fahn, Eds.), pp. 166-230. Butterworth, London.
2. Akaneya, Y., M. Takahashi,and H. Hatanaka. 1995. Interleukin-1β enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp. Neurol. 136: 44-52.
3. Araujo, D. M., and C. W. Cotman. 1992. Basic FGF in astroglial, microglial, and neuronal cultures: Characterization of binding sites and modulation of release by lymphokines and trophic factors. J. Neurosci. 12: 1668-1678.
4. Aviezer, D., D. Hecht, M. Safran, M. Elsinger, G. David,and A. Yayon. 1994. Perlecan, basal lamina proteoglycan, promotes basic FGF-receptor binding, mitogenesis and angiogenesis. Cell 79: 1005-1013.
5. Bankiewicz, K. S., R. J. Plunkett, D. M. Jacobowitz, L. Porrino, U. DiPorzio, W. London, I. J. Kopin,and E. H. Oldfield. 1990. The effect of fetal mesencephalic implants on primate MPTP-induced parkinsonism. J. Neurosurg. 72: 231-244.
6. Bankiewicz, K. S., R. J. Plunkett, D. M. Jacobowitz, I. J. Kopin, and E. H. Oldfield. 1991. Sprouting-induced recovery from MPTP-induced parkinsonism in primates after fetal non-dopaminergic brain implants: Histochemical and behavioral studies. J. Neurosurg. 74: 97-101.
7. Bartfai, T., and M. Schultzberg. 1993. Cytokines in neuronal cell types. Neurochem. Int. 22: 435-444.
8. Benveniste, E. N. 1992. Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action. Am. J. Physiol. 263: C1-C6.
9. Bernheimer, H., W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger. 1973. Brain dopamine and the syndromes of Parkinson and Huntington. J. Neurol. Sci. 20: 415-455.
10. Berry, M., W. L. Maxwell, A. Logan, A. Mathewson, P. McConnell, D. Ashhurst,and G. H. Thomas. 1983. Deposition of scar tissue in the central nervous system. Acta Neurochir. 32(suppl): 31-53.
11. Blanchard, V., M. Chritin, S. Vyas, M. Savasta, C. Feuerstein, Y. Agid, F. Javoy-Agid,and R. Raisman-Vozari. 1995. Long-term induction of tyrosine hydroxylase expression: Compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain. J. Neurochem. 64: 1669-1679.
12. Blum, M. 1989. Regulation of neuroendocrine peptide gene expression. In Methods in Enzymology (P. M. Conn, Ed.), Vol. 168, pp 618-633. Academic Press, San Diego.
13. Blum, M., and C. S. Weichert. 1995. GDNF mRNAexpression in normal postnatal development, aging, and in weaver mutant mice. Neurobiol. Aging 16: 925-929.
14. Bohn, M. C., L. Cupit, F. Marciano,and D. M. Gash. 1987. Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237: 913-916.
15. Brodkey, J. A., M. A. Gates, E. D. Laywell,and D. A. Steindler. 1993. The complex nature of interactive neuroregeneration-related molecules. Exp. Neurol. 123: 251-270.
16. Chadi, G., Y. Cao, R. F. Pettersson,and K. Fuxe. 1994. Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons. Neuroscience 61: 891, 910.
17. Cintra, A., Y. H. Cao, C. Oellig, B. Tinner, F. Bortolotti, M. Goldstein, R. F. Pettersson,and K. Fuxe. 1991. Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat. NeuroReport 2: 597-600.
18. Coelin, R. V., K. Unsicker,and K. Krieglstein. 1995. Screening of interleukins for survival-promoting effects on cultured mesencephalic dopaminergic neurons from embryonic rat brain. Dev. Brain Res. 89: 150-154.
19. Cotman, C. W., A. J. Tenner,and B. J. Cumming. 1996. β-Amyloid converts an acute phase injury response to chronic injury responses. Neurobiol. Aging 17: 723-731.
20. Date, I., D. L. Felten,and S. Y. Felten. 1990. Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. Brain Res. 519: 266-276.
21. Date, I., M. F. D. Notter, S. Y. Felten,and D. L. Felten. 1990b. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF). Brain Res. 526: 156-160.
22. Eddleston, M., and L. Mucke. 1993. Molecular profile of reactive astrocytes - Implications for their role in neurologic disease. Neuroscience 54: 15-36.
23. Ewing, S. E., R. J. Weber, A. Zauner,and R. J. Plunkett. 1992. Recovery in hemiparkinsonian rats following intrastriatal implantation of activated leukocytes. Brain Res. 576: 42-48.
24. Fiandaca, M. S., J. H. Kordower, J. T. Hansen, S. S. Jiao, and D. M. Gash. 1988. Adrenal medullary autografts into the basal ganglia of Cebus monkeys: Injury-induced regeneration. Exp. Neurol. 102: 76-91.
25. Fontana, A., F. Kristensen, R. Dubs, D. Gemsa,and E. Weber. 1982. Production of prostaglandin E and interleukin-1 like factor by cultured astrocytes and C glioma cells. J. Immunol. 129: 2413-2419.
26. Gage, F. H., P. Olejniczak,and D. M. Armstrong. 1988. Astrocytes are important for sprouting in the septohippocampal circuit. Exp. Neurol. 102: 2-13.
27. Garfinkel, S., X. Hu, I. A. Prudovsky, G. A. McMahon, E. M. Kapnik, S. D. McDowell,and T. Maciag. 1996. FGF-1-dependent proliferative and migratory responses are impaired in senescent human umbilical vein endothelial cells and correlate with the inability to signal tyrosine phosphorylation of fibroblast growth factor receptor-1 substrates. J. Cell. Biol. 134: 783-791.
28. Giulian, D. 1992. Microglia and disease of the nervous system. Curr. Top. Neurol. 12: 23-54.
29. Giulian, D., and T. J. Baker. 1985. Peptides released by ameboid microglia regulate astroglial proliferation. J. Cell. Biol. 101: 2411-2415.
30. Giulian, D., and L. B. Lachman. 1985. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228: 497-499.
31. Giulian, D., R. Allen, T. J. Baker,and Y. J. Tomozawa. 1986. Brain peptides and glial growth. 1. Glia-promoting factors as regulators of gliogenesis in the developing and injured central nervous system. J. Cell. Biol. 102: 803-811.
32. Giulian, D., T. J. Baker, L. N. Shin,and L. B. Lachman. 1986. Interleukin-1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164: 594-604.
33. Giulian, D., J. Woodward, D. G. Young, J. F. Krebs,and L. B. Lachman. 1988. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8: 2485-2490.
34. Giulian, D., D. G. Young, J. Woodward, D. C. Brown,and L. B. Lachman. 1988. Interleukin-1 is an astroglial growth factor in the developing brain. J. Neurosci. 8: 709-714.
35. Giulian, D., K. Vaca,and M. Corpuz. 1993. Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13: 29-37.
36. Gospodarowicz, D., G. Neufeld,and L. Schweigerer. 1986. Molecular and biological characterization of fibroblast growth factor: An angiogenic factor which controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell. Differ. 19: 1.
37. Gospodarowicz, D., N. Ferrara, L. Schweigerer,and G. Neufeld. 1987. Structural characterization and biological functions of fibroblast growth factor. Endocr. Rev. 8: 95-114.
38. Hansen, J. T., M. S. Fiandaca, J. H. Kordower, M. F. D. Notter, and D. M. Gash. 1990. Striatal adrenal medulla/sural nerve cografts in hemiparkinsonian monkeys. Prog. Brain Res. 82: 573-580.
39. Hansen, J. T., K. Sakai, J. T. Greenamyre,and S. Moran. 1995. Sprouting of dopaminergic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat. Brain Res. 670: 197-204.
40. Hatten, M. E., G. Fishell, T. N. Stitt,and C. A. Mason. 1990. Astroglia as a scaffold for development of the CNS. Semin. Neurosci. 2: 455-465.
41. Hatten, M. E., R. K. H. Liem, M. L. Shelanski,and C. A. Mason. 1991. Astroglia in the CNS injury. Glia 4: 233-243.
42. Hetier, E., J. Ayala, P. Denefle, A. Bousseau, P. Rouget, M. Malat,and A. Prochiantz. 1988. Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro. J. Neurosci. Res. 21: 391-397.
43. Hirsch, E., A. M. Graybiel,and Y. A. Agid. 1988. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334: 345-348.
44. Ho, A., A. C. Gore, C. S. Weickert,and M. Blum. 1995. Glutamate regulation of GDNF gene expression in the striatum and primary striatal astrocytes. NeuroReport 6: 1454-1458.
45. Hodes, R. J. 1995. Molecular alterations in the aging immune system. J. Exp. Med. 182: 1-3.
46. Lawrence, J. M., R. J. Morris, D. J. Wilson,and G. Raisman. 1990. Mechanisms of allograft rejection in the rat brain. Neuroscience 37: 431-462.
47. Leonard, S., D. Luthman, J. Logel, J. Luthman, C. Antle, R. Freedman,and B. Hoffer. 1993. Acidic and basic fibroblast growth factor mRNAs are increased in striatum following MPTP-induced dopamine neurofiber lesion: Assay by quantitative PCR. Mol. Brain Res. 18: 275-284.
48. Lieberman, A. P., P. M. Pitha, H. S. Shin,and M. L. Shin. 1989. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotrophic virus. Proc. Natl. Acad. Sci. USA 86: 56348-56352.
49. Lindholm, D., R. Heumann, M. Meyer,and H. Thoenen. 1987. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330: 658-659.
50. McKeon, R. J., R. C. Schreiber, J. S. Rudge,and J. Silver. 1991. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J. Neurosci. 11: 3398-3411.
51. Meiners, S., M. Marone, J. L. Rittenhouse,and H. M. Geller. 1993. Regulation of astrocytic tenascin by basic fibroblast growth factor. Dev. Biol. 160: 480-493.
52. Meiners, S., E. M. Powell,and H. M. Geller. 1995. A distinct subset of tenascin/CS-6-PG-rich astrocytes restricts neuronal growth in vitro. J. Neurosci. 15: 8096-8101.
53. Nieto-Sampedro, M., and M. A. Berman. 1987. Interleukin-1 like activity in rat brain: Sources, targets, and effect of injury. J. Neurosci. Res. 17: 214-219.
54. Nurcombe, V., M. D. Ford, P. F. Wildschut,and P. Barlett. 1993. Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 260: 103-106.
55. Otto, D., and K. Unsicker. 1990. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J. Neurosci. 10: 1912-1921.
56. Perry, V. H., and S. Gordon. 1988. Macrophages and microglia in the nervous system. Trends Neurosci. 11: 273-277.
57. Pickel, V. M., E. Johnson, M. E. Carsson,and J. Chan. 1992. Compensatory changes in ultrastructure of spared dopaminergic terminals in caudate-putamen nuclei of adult rats receiving neonatal intranigral 6-hydroxydopamine. Dev. Brain Res. 70: 75-86.
58. Plunkett, R. J., K. S. Bankiewicz, A. C. Cummins, R. S. Miletich, J. P. Schwartz,and E. H. Oldfield. 1990. Long-term evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation alone. J. Neurosurg. 73: 918-926.
59. Reenstra, W. R., M. Yaar,and B. A. Gilchrest. 1993. Effect of donor age on epidermal growth factor processing in man. Exp. Cell Res. 209: 118-122.
60. Reenstra, W. R., M. Yaar,and B. A. Gilchrest. 1996. Aging affects epidermal growth factor receptor phosphorylation and traffic kinetics. Exp. Cell Res. 227: 252-255.
61. Reier, P. J. 1986. Gliosis following CNS injury: The anatomy of astrocytic scars and their influences on axonal elongation. In Astrocytes: Cell Biology and Pathology of Astrocytes (S. Federoff and A. Vernadakis, Eds.), pp 263-324. Academic Press, Orlando, FL.
62. Reier, P. J., and J. Houle. 1988. The glial scar: Its bearing on axonal elongation and transplantation approaches to CNS repair. InAdvances in Neurology: Functional Recovery in Neurological Disease (S. G. Waxman, Ed.), pp 87-138. Raven Press, New York.
63. Reier, P. J., L. J. Stensaas,and L. Guth. 1983. The astrocytic scar as an impediment to regeneration in the central nervous system. In Fundamentals of Spinal Cord Reconstruction (C. C. Kao, R. P. Bunge, and P. J. Reier, Eds), pp. 163-195. Raven Press, New York.
64. Reier, P. J., L. F. Eng,and L. Jakeman. 1989. Reactive astrocyte and axonal outgrowth in the injured CNS: Is gliosis really an impediment to regeneration? In Neural Regeneration and Transplantation (F. J. Seil, Ed.), pp. 183-209. Alan R. Liss, New York.
65. Ricaurte, G. A., L. E. DeLanney, I. Irwin,and J. W. Langston. 1987. Older dopaminergic neurons do not recover from the effects of MPTP. Neuropharmacology 26: 97-99.
66. Ricaurte, G. A., I. Irwin, L. S. Forno, L. E. DeLanney, E. Langston,and J. W. Langston. 1987. Aging and l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res. 403: 43-51.
67. Rivera, S., S. J. Gold,and C. M. Gall. 1994. Interleukin-1β increases basic fibroblast growth factor mRNA expression in adult rat brain and organotypic hippocampal cultures. Mol. Brain Res. 27: 12-26.
68. Rothwell, N. J., and P. J. L. M. Strijbos. 1995. Cytokines in neurodegeneration and repair. Int. J. Dev. Neurosci. 13: 179-185.
69. Rudge, J. S., and J. Silver. 1990. Inhibition of neurite outgrowth on astroglial scars in vitro. J. Neurosci. 10: 3594-3603.
70. Rudge, J. S., G. M. Smith,and J. Silver. 1989. An in vitro model of wound healing in the CNS: Analysis of cell reaction and interaction at different ages. Exp. Neurol. 103: 1-16.
71. Sawada, M., A. Suzumura,and T. Marunouchi. 1995. Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int. J. Dev. Neurosci. 13: 253-264.
72. Shimasaki, S., N. Emoto, A. Koba, M. Mercado, F. Shibata, K. Cooksey, A. Baird,and N. Ling. 1988. Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA. Biochem. Biophys. Res. Commun. 157: 256-263.
73. Sievers, J., G. Struckhoff,and M. Puchner. 1993. Interleukin-1β does not induce reactive astrogliosis, neovascularization or scar formation in the immature rat brain. Int. J. Dev. Neurosci. 11: 281-293.
74. Smith, G. M., R. H. Miller,and J. Silver. 1986. Changing role of forebrain astrocytes during development, regenerative failure, and induced regeneration upon transplantation. J. Comp. Neurol. 251: 23-13.
75. Smith, G. M., U. Rutishauser, J. Silver,and R. H. Miller. 1990. Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth. Dev. Biol. 138: 377-390.
76. Spranger, M., D. Lindholm, C. Bandtlow, R. Heumann, H. Gnahn, M. Näher-Noé,and H. Thoenen. 1990. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: Comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2: 69-76.
77. Strömberg, I., L. Björklund, M. Johansson, A. Tomac, F. Collins, L. Olson, B. J. Hoffer,and C. Humpel. 1993. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124: 401-412.
78. Tomac, A., E. Lindqvist, L-F.H. Lin, S. O. Ögren, D. Young, B. J. Hoffer,and L. Olson. 1995. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335-339.
79. Tomaselli, K. J., L. F. Reichardt,and J. L. Bixby. 1986. Distinct molecular interactions mediate neuronal process outgrowth on nonneuronal cell surfaces and extracellular matrices. J. Cell Biol. 103: 2659-2672.
80. Wang, J., K. S. Bankiewicz, R. J. Plunkett, J. Sheng,and D. M. Jacobowitz. 1991. Transplantation of microglia reduces experimental parkinsonism in rats. In Intracerebral Transplantation in Movement Disorders (O. Lindvall, A. Björklund, and H. Widner, Eds.), pp. 313-323. Elsevier, Amsterdam.
81. Wang, J., K. S. Bankiewicz, R. J. Plunkett,and E. H. Oldfield. 1994. Intrastriatal implantation of interleukin-1: Reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain. J. Neurosurg. 80: 484-490.
82. Wang, L-C., D. H. Baird, M. E. Hatten,and C. A. Mason. 1994. Astroglial differentiation is required for support of neurite outgrowth. J. Neurosci. 14: 3195-3207.
83. Yoshida, K., and F. H. Gage. 1992. Cooperative regulation of nerve growth factor synthesis and secretion in fibroblasts and astrocytes by fibroblast growth factor and other cytokines. Brain Res. 569: 14-25.